Index by author

August 01, 2004; Volume 71,Issue 8

  1. Bhakta, Shyam

    1. Angiotensin-receptor blockers in heart failure
      Shyam Bhakta, MD and Mark E. Dunlap, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 665-673;

      The ARB candesartan was not only a good alternative to an ACE inhibitor, it was beneficial when added to a regimen that already included an ACE inhibitor and a beta-blocker.

  2. Clough, John D.

    1. The angiotensin story continues: ARBs in heart failure
      John D. Clough, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 606;

      Considering the gravity of the problem of heart failure, it makes sense to have as many alternative pathways to success as we can find.

  3. Collantes, Rochelle

    1. Nonalcoholic fatty liver disease and the epidemic of obesity
      Rochelle Collantes, MD, MPH, Janus P. Ong, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 657-664;

      Nonalcoholic fatty liver disease, unknown only 2 decades ago, is now ubiquitous, especially among the obese.

  4. Davidson, Michael B.

    1. Evaluation of hyponatremia: A little physiology goes a long way
      Benjamin J. Freda, DO, Michael B. Davidson, DO and Phillip M. Hall, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 639-650;

      A careful and logical approach can promptly reveal the causative factor or factors in nearly all cases.

  5. Davis, Mellar P.

    1. Cancer pain: How to measure the fifth vital sign
      Mellar P. Davis, MD and Declan Walsh, MSc
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 625-632;

      To control pain effectively in cancer patients, we must assess it regularly and consistently.

  6. Dunlap, Mark E.

    1. Angiotensin-receptor blockers in heart failure
      Shyam Bhakta, MD and Mark E. Dunlap, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 665-673;

      The ARB candesartan was not only a good alternative to an ACE inhibitor, it was beneficial when added to a regimen that already included an ACE inhibitor and a beta-blocker.

  7. Freda, Benjamin J.

    1. Evaluation of hyponatremia: A little physiology goes a long way
      Benjamin J. Freda, DO, Michael B. Davidson, DO and Phillip M. Hall, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 639-650;

      A careful and logical approach can promptly reveal the causative factor or factors in nearly all cases.

  8. Hall, Phillip M.

    1. It’s what’s inside the white coat that counts
      Phillip M. Hall, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 607-608;

      Welcoming the first class of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

    2. Evaluation of hyponatremia: A little physiology goes a long way
      Benjamin J. Freda, DO, Michael B. Davidson, DO and Phillip M. Hall, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 639-650;

      A careful and logical approach can promptly reveal the causative factor or factors in nearly all cases.

  9. Khush, Kiran K.

    1. Lessons from the PROVE-IT Trial
      Kiran K. Khush, MD and David Waters, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 609-616;

      Patients with acute coronary syndromes should receive aggressive lipid-lowering therapy with a statin in high doses. Goal low-density lipoprotein levels may need to be lower.

  10. Lesho, Emil P.

    1. A 76-year-old woman with erratic anticoagulation
      Emil P. Lesho, DO, Louise Saullo, CRTT and Szilvia Udvari-Nagy, MD
      Cleveland Clinic Journal of Medicine August 2004, 71 (8) 651-656;

      A patient previously controlled on warfarin now has bleeding and an INR of 7. What has changed?

« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue